ModernaTX, Inc. - 07 Mar 2023 Form 3 Insider Report for Carisma Therapeutics Inc. (CARM)

Role
10%+ Owner
Signature
Brian Sandstrom, Assistant Secretary
Issuer symbol
CARM
Transactions as of
07 Mar 2023
Net transactions value
$0
Form type
3
Filing time
13 Mar 2023, 17:06:46 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding CARM Common Stock 5,059,338 07 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Pursuant to a reverse-merger transaction consummated on March 7, 2023, the Reporting Person became the beneficial owner of 12.57% of the Issuer's total shares outstanding.